Rapid molecular testing for bioterrorism agents: Targets, tactics, and technology

Deborah Ann Payne, John Petersen

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Biological agents most likely to be used as bioweapons are those that are easily disseminated, highly infectious, and would significantly impact the feeling of security of a given population. Rapid detection of these agents would help counteract the strategic and tactical usefulness of these bioweapons. Point-of-care-testing (POCT) helps the healthcare provider in making a differential diagnosis and while it is the ultimate goal for nucleic acid/molecular testing especially for the area of biodefense, additional technological advances are required before it can be offered clinically. Even though testing for agents with bioweapon potential is not the focus of most clinical molecular pathology laboratories, the prevalence and rapidity of diagnostic nucleic acid based assays supports their use for this application. This review will focus on the targets, tactics and technology for rapid detection of nucleic acids using current and emerging technologies as it applies to biodefense.

Original languageEnglish (US)
Pages (from-to)348-357
Number of pages10
JournalJournal of Clinical Ligand Assay
Volume25
Issue number4
StatePublished - Dec 2002
Externally publishedYes

Fingerprint

Biological Warfare Agents
Nucleic Acids
Technology
Testing
Clinical Pathology
Molecular Pathology
Biological Factors
Pathology
Health Personnel
Assays
Emotions
Differential Diagnosis
Population

Keywords

  • Bed side testing
  • DNA
  • Infectious
  • Molecular diagnostics
  • Nucleic acid testing (NAT)
  • Polymerase chain reaction (PCR)
  • Rapid thermocylcer
  • RNA
  • Terrorism

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Immunology

Cite this

Rapid molecular testing for bioterrorism agents : Targets, tactics, and technology. / Payne, Deborah Ann; Petersen, John.

In: Journal of Clinical Ligand Assay, Vol. 25, No. 4, 12.2002, p. 348-357.

Research output: Contribution to journalArticle

Payne, Deborah Ann ; Petersen, John. / Rapid molecular testing for bioterrorism agents : Targets, tactics, and technology. In: Journal of Clinical Ligand Assay. 2002 ; Vol. 25, No. 4. pp. 348-357.
@article{471fb862e1a6482eb6c46917a439e2f6,
title = "Rapid molecular testing for bioterrorism agents: Targets, tactics, and technology",
abstract = "Biological agents most likely to be used as bioweapons are those that are easily disseminated, highly infectious, and would significantly impact the feeling of security of a given population. Rapid detection of these agents would help counteract the strategic and tactical usefulness of these bioweapons. Point-of-care-testing (POCT) helps the healthcare provider in making a differential diagnosis and while it is the ultimate goal for nucleic acid/molecular testing especially for the area of biodefense, additional technological advances are required before it can be offered clinically. Even though testing for agents with bioweapon potential is not the focus of most clinical molecular pathology laboratories, the prevalence and rapidity of diagnostic nucleic acid based assays supports their use for this application. This review will focus on the targets, tactics and technology for rapid detection of nucleic acids using current and emerging technologies as it applies to biodefense.",
keywords = "Bed side testing, DNA, Infectious, Molecular diagnostics, Nucleic acid testing (NAT), Polymerase chain reaction (PCR), Rapid thermocylcer, RNA, Terrorism",
author = "Payne, {Deborah Ann} and John Petersen",
year = "2002",
month = "12",
language = "English (US)",
volume = "25",
pages = "348--357",
journal = "Journal of Clinical Ligand Assay",
issn = "1081-1672",
publisher = "Clinical Ligand Assay Society Inc.",
number = "4",

}

TY - JOUR

T1 - Rapid molecular testing for bioterrorism agents

T2 - Targets, tactics, and technology

AU - Payne, Deborah Ann

AU - Petersen, John

PY - 2002/12

Y1 - 2002/12

N2 - Biological agents most likely to be used as bioweapons are those that are easily disseminated, highly infectious, and would significantly impact the feeling of security of a given population. Rapid detection of these agents would help counteract the strategic and tactical usefulness of these bioweapons. Point-of-care-testing (POCT) helps the healthcare provider in making a differential diagnosis and while it is the ultimate goal for nucleic acid/molecular testing especially for the area of biodefense, additional technological advances are required before it can be offered clinically. Even though testing for agents with bioweapon potential is not the focus of most clinical molecular pathology laboratories, the prevalence and rapidity of diagnostic nucleic acid based assays supports their use for this application. This review will focus on the targets, tactics and technology for rapid detection of nucleic acids using current and emerging technologies as it applies to biodefense.

AB - Biological agents most likely to be used as bioweapons are those that are easily disseminated, highly infectious, and would significantly impact the feeling of security of a given population. Rapid detection of these agents would help counteract the strategic and tactical usefulness of these bioweapons. Point-of-care-testing (POCT) helps the healthcare provider in making a differential diagnosis and while it is the ultimate goal for nucleic acid/molecular testing especially for the area of biodefense, additional technological advances are required before it can be offered clinically. Even though testing for agents with bioweapon potential is not the focus of most clinical molecular pathology laboratories, the prevalence and rapidity of diagnostic nucleic acid based assays supports their use for this application. This review will focus on the targets, tactics and technology for rapid detection of nucleic acids using current and emerging technologies as it applies to biodefense.

KW - Bed side testing

KW - DNA

KW - Infectious

KW - Molecular diagnostics

KW - Nucleic acid testing (NAT)

KW - Polymerase chain reaction (PCR)

KW - Rapid thermocylcer

KW - RNA

KW - Terrorism

UR - http://www.scopus.com/inward/record.url?scp=0038675414&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038675414&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0038675414

VL - 25

SP - 348

EP - 357

JO - Journal of Clinical Ligand Assay

JF - Journal of Clinical Ligand Assay

SN - 1081-1672

IS - 4

ER -